SO THE US RETT TRIAL EXTENSION [1] IS 48 WEEKS ALSO?
ARE EXTENSION TRIALS CHEAPER IN THE US ALSO?
To offer all participants access to ANAVEX®2-73 (blarcamesine) after completion of the ANAVEX®2-73 (blarcamesine) U.S. Phase 2 Rett syndrome study[1] and the AVATAR Rett syndrome study[2], 12-week and 48-week open-label extension studies, respectively were initiated.